Citation 78707

KAKEYA,H: MORISHITA,M: ONOZAWA,C: USAMI,R: HORIKOSHI,K: KIMURA,K: YOSHIHAMA,M: OSADA,H:. (1997). RKS-1778, A NEW MAMMALIAN CELL-CYCLE INHIBITOR AND A KEY INTERMEDIATE OF THE [11]CYTOCHALASIN GROUP.. 60(7)

Citation Details

Title	RKS-1778, A NEW MAMMALIAN CELL-CYCLE INHIBITOR AND A KEY INTERMEDIATE OF THE [11]CYTOCHALASIN GROUP.
Authors	KAKEYA,H: MORISHITA,M: ONOZAWA,C: USAMI,R: HORIKOSHI,K: KIMURA,K: YOSHIHAMA,M: OSADA,H:
Year	1997
Volume	60
Issue	7

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Phoma species (COELOMYCETES)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CYTOCHALASIN,[11]: RKS-1778	None
2	CELL CYCLE CYTOTOXICITY(M PHASE)	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOCHALASIN,[11]: RKS-1778	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOCHALASIN,[11]: RKS-1778	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	CYTOCHALASIN H,EPOXY:	None
5	CELL CYCLE CYTOTOXICITY(M PHASE)	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOCHALASIN H,EPOXY:	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOCHALASIN H,EPOXY:	ACTIVE

Show SPARQL Queries (1)